A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

Related Clinical Trial
A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia Letrozole as a Prophylaxis From GTN for Complete Mole Patients Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6 Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) Camrelizumab Combined With Apatinib for Recurrent Resistant GTN The French National Reference Centre of GTD Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP) Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia

Recruitment Information


Administrative Informations